QP Cold Multi-Symptom medication recalled for improper storage conditions
Family Dollar Stores is recalling QP Cold Multi-Symptom Day/Night medication distributed April 30–June 10, 2022, to select stores because the product was held at incorrect temperatures. Consumers should return the product to the store for a refund.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is a Class II pharmaceutical recall with no reported illnesses, injuries, or deaths. The hazard is improper storage temperature, a CGMP compliance and quality control issue rather than a high-risk pathogen or allergen. The recall is precautionary in nature.
Plain-English summary
Family Dollar Stores, Llc. is recalling QP Cold Multi-Symptom Day/Night Complete 24-count medication (SKU: 916058) that was distributed to select Family Dollar Stores between April 30, 2022, and June 10, 2022.
The product is being recalled because it was held outside appropriate storage temperature conditions, which constitutes a deviation from Current Good Manufacturing Practice (CGMP) standards.
The affected product was distributed to specific Family Dollar Stores nationwide during the recall period.
Consumers who purchased this medication should stop using it and return it to the store where it was purchased for a refund.
The recalled product
- Product
- QP COLD MULTI SYMPTM DAY NITE CPLT 24 CT distributed to specific Family Dollar Stores 04/30/2022 through 06/10/2022.
- Manufacturer
- Family Dollar Stores, Llc.
- Category
- Drug — Cold Medication
- Hazard
- improper-storage-temperature
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- SKU: 916058
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27